ArticleCureus2024
Cardiac Tamponade: A Late and Rare Finding of Hypothyroidism.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
"Myxedema heart" is a rare syndrome that results from severe untreated hypothyroidism. It is characterized by relative bradycardia, low-voltage electrocardiogram (EKG), cardiomyopathy, and pericardial effusion. Here, we present a case of cardiac tamponade in untreated hypothyroidism. A 49-year-old male with no prior medical or psychiatric history presented to the Emergency Department for cognitive slowing, weakness, and inappropriate behavior for several weeks. Vital signs were significant for bradycardia with normal blood pressure. Examination revealed that the patient was disheveled and alert but forgetful with slow speech, along with ataxia and muscle wasting. The EKG showed low-voltage sinus bradycardia. Laboratory workup was notable for an elevated thyroid-stimulating hormone (TSH) level of more than 100 mcIU/mL, with low free T4 and T3. Anti-thyroid peroxidase (TPO) and thyroglobulin antibodies were elevated, confirming a diagnosis of Hashimoto's thyroiditis. Treatment with intravenous levothyroxine, triiodothyronine, and hydrocortisone was started. An echocardiogram revealed a large circumferential pericardial effusion with evidence of tamponade. A pericardial drain was placed, and it drained 980 mL of sanguineous fluid. Serial echocardiograms showed a stable posterior effusion with no recurrence of the anterior pericardial effusion. Gradually, the patient's mentation, hemodynamics, and electrolyte levels improved. He was discharged on oral levothyroxine. TSH values showed sequential improvement. A large pericardial effusion with tamponade is a rare, life-threatening complication of untreated hypothyroidism. Clinicians must promptly identify myxedema and replace thyroid hormone to prevent the progression of pericardial effusion to tamponade and reverse its pathophysiology, maintaining a high level of suspicion in those at risk of poor healthcare access or inadequate health literacy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.